Garzone, Davide
Terheyden, Jan Henrik
Morelle, Olivier
Wintergerst, Maximilian W. M.
Saßmannshausen, Marlene
Schmitz-Valckenberg, Steffen
Pfau, Maximilian
Thiele, Sarah
Poor, Stephen
Leal, Sergio
Holz, Frank G.
Finger, Robert P.
Agostini, H.
Altay, L.
Atia, R.
Bandello, F.
Basile, P. G.
Behning, C.
Belmouhand, M.
Berger, M.
Binns, A.
Boon, C. J. F.
Böttger, M.
Bouchet, C.
Brazier, J. E.
Butt, T.
Carapezzi, C.
Carlton, J.
Carneiro, A.
Charil, A.
Coimbra, R.
Cozzi, M.
Crabb, D. P.
Cunha-Vaz, J.
Dahlke, C.
de Sisternes, L.
Dunbar, H.
Fletcher, E.
Francisco, C.
Gutfleisch, M.
Hogg, R.
Hoyng, C. B.
Kilani, A.
Krätzschmar, J.
Kühlewein, L.
Larsen, M.
Lechanteur, Y. T. E.
Luhmann, U. F. O.
Lüning, A.
Marques, I.
Martinho, C.
Montesano, G.
Mulyukov, Z.
Paques, M.
Parodi, B.
Parravano, M.
Penas, S.
Peters, T.
Peto, T.
Priglinger, S.
Rowen, D.
Rubin, G. S.
Sahel, J.
Sánchez, C.
Sander, O.
Schmid, M.
Schrinner-Fenske, H.
Siedlecki, J.
Silva, R.
Skelly, A.
Souied, E.
Staurenghi, G.
Stöhr, L.
Taylor, D. J.
Tufail, A.
Varano, M.
Vieweg, L.
Wintergerst, L.
Wolf, A.
Zakaria, N.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report
https://doi.org/10.1136/bjophthalmol-2021-320848
Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report
https://doi.org/10.1038/s41598-022-26223-w
Funding for this research was provided by:
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 23 July 2022
Accepted: 12 December 2022
First Online: 19 December 2022
Change Date: 7 March 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41598-023-30360-1
Competing interests
: DG: None. JHT: Heidelberg Engineering (F), Optos (F), Zeiss (F), CenterVue (F), Novartis (R), Okko (R). OM: None. MWMW: MWMW: Heidelberg Engineering (F, R), Optos (F), Carl Zeiss Meditec (F), CenterVue (F), Heine Optotechnik GmbH (C, R, F), Berlin-Chemie AG (F), Novartis Pharma GmbH (R, F), D-Eye Srl (F), Eyenuk Inc. (F), ASKIN & CO GmbH (R), DigiSight Technologies (R). MS: Heidelberg Engineering (F), CenterVue (F), Carl Zeiss MedicTec (F). SSV: AlphaRET (C), Apellis (C, R), Bayer (F), Bioeq (C), Carl Zeiss MediTec (F), Heidelberg Engineering (F, R), Katairo (C), Kubota Vision (C), Novartis (C, F), Oxurion (C), Pixium (C), Roche (C, F), SparingVision (C), STZ GRADE Reading Center (O). MP: Apellis Pharmaceuticals (C). SHT: Heidelberg Engineering (R, F); Optos (F), Zeiss (F), CenterVue (F); Novartis (R); Bayer (R); Allergan (R). SP: Novartis (E). SL: Bayer (E). FGH: Acucela (C,F), Allergan (F), Apellis (C, F), Bayer (C, F), Boehringer-Ingelheim (C), Bioeq/Formycon (F,C), CenterVue (F), Ellex (F), Roche/Genentech (C,F), Geuder (C,F), Graybug (C), Gyroscope (C), Heidelberg Engineering (C,F), IvericBio (C, F), Kanghong (C,F), LinBioscience (C), NightStarX (F), Novartis (C,F), Optos (F), Oxurion (C), Pixium Vision (C,F), Oxurion (C), Stealth BioTherapeutics (C), Zeiss (F,C), GRADE Reading Center (O). RPF: Bayer, Santen, Ophtea, Apellis, Roche/Genentech, Böhringer-Ingelheim, Novelion, ProQR, Oxford Innovation, Roche, Alimera, Santhera, Inositec, Ellex.